Last reviewed · How we verify
BMN 190
At a glance
| Generic name | BMN 190 |
|---|---|
| Also known as | recombinant human tripeptidyl peptidase-1 (rhTPP1), cerliponase alfa |
| Sponsor | BioMarin Pharmaceutical |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- BMN 190 CI brief — competitive landscape report
- BMN 190 updates RSS · CI watch RSS
- BioMarin Pharmaceutical portfolio CI